BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Ebola outbreak
    • Hantavirus
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Thursday, June 18, 2026
Home » SARS-CoV-2

Articles Tagged with ''SARS-CoV-2''

Regulatory actions for Sept. 15, 2020

Sep. 15, 2020
Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Cerapedics, Controlrad, Eurobio Scientific, Fibralign, GE Healthcare, Genmark Diagnostics.
Read More

Other news to note for Sept. 15, 2020

Sep. 15, 2020
Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Anpac Bio-Medical Science, Apple, Bostongene, Cardiacsense, Chest Foundation, Concept Medical, Controlrad, Fujifilm Sonosite, Genetic Technologies, Global Plasma Solutions, Illumina, Movendo, Nihon Kohden, Palisade, Polyganics, Sherlock Biosciences, Ursa Health, Visage, Welldoc.
Read More

Other news to note for Sept. 14, 2020

Sep. 14, 2020
Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Applied Spectral Imaging, Astrazeneca, Avita Therapeutics, Bio-Techne, Guided Therapeutics, Kantaro Biosciences, Luminultra, Meridian, Mimedx, Mount Sinai Health, Natera, Nevro, Shandong Yaohua Medical Instrument, Staar Surgical, Telo Genomics, Thermo Fisher Scientific, Transenterix.
Read More
Microscope and coronavirus illustration

Shuren, Stenzel reiterate plea for LDT legislation in NEJM editorial

Sep. 10, 2020
By Mark McCarty
The rescission order directing the U.S. FDA to abandon regulation of lab-developed tests is scarcely three weeks in the past, but two senior managers at the FDA are pushing back in an editorial appearing in the New England Journal of Medicine. The FDA’s Jeff Shuren and Tim Stenzel wrote that there is “a need for a common legislative framework” to ensure clinical tests are accurate and reliable, which implicitly concedes that the statute does not authorize the agency to regulate lab-developed tests.
Read More

BioWorld MedTech’s Diagnostics Extra for Sept. 10, 2020

Sep. 10, 2020
By Anette Breindl and Meg Bryant
Keeping you up to date on recent developments in diagnostics, including: Deep learning aid for diagnosing TB in HIV patients; Self-collected swabs vs. health care worker collected for COVID-19 testing; SCAD vs. plaques in heart attacks; Diagnosing neuroblastoma in children.
Read More

Regulatory actions for Sept. 10, 2020

Sep. 10, 2020
Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Boston Scientific, Exsomed, Glaxosmithkline, Innoviva, Izi Medical, Verily.
Read More

In the clinic for Sept. 10, 2020

Sep. 10, 2020
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Avenu Medical, Axonics, Hyperfine, Medifiber, Reshape Lifesciences.
Read More
Digital illustration of U.S., coronavirus

Ultra-sensitive antigen testing could help identify patients at risk for severe COVID-19

Sep. 9, 2020
By Mary Ellen Schneider
A new type of SARS-CoV-2 antigen test that relies on single molecule array technology may be able to help clinicians identify which patients are most likely to experience severe disease.
Read More

Other news to note for Sept. 9, 2020

Sep. 9, 2020
Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Ambu, Analog Devices, A.R.C. Laser, Avricore Health, Benchmark Electronics, Change Healthcare, Clearside Biomedical, Coracoid Solutions, Coremap, D&D Pharmatech, Dnanudge, Evonetix, Fotona, Genova Diagnostics, Gogomeds, Hospitec, Joint Commission, Kit Check, Lifelabs, Livongo, Lncbio, Magellan Health, Medline Industries, Nanostring, Nanox, Orexo, Paradise Genomics, Parvizi Surgical Innovation, Personal Genome Diagnostics, Pharmigene, Regenexbio, Respiration, Rocky Mountain Analytical, S2 Genomics, Sca Pharma, Scrum, Spi Medical, Sqi Diagnostics, Thermo Fisher Scientific, Thrive Health, Thunderbio Science, Trendbio, Vizient.
Read More

In the clinic for Sept. 9, 2020

Sep. 9, 2020
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Alydia Health, BD, Dreamed Diabetes, Sight Sciences.
Read More
Previous 1 2 … 94 95 96 97 98 99 100 101 102 … 136 137 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for June 18, 2026.
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for June 16, 2026
  • Red blood cells, DNA

    For clonal hematopoiesis, epigenetics can be in driver’s seat

    BioWorld Science
    Clonal hematopoiesis (CH), where few blood stem cells produce a significant fraction of mature blood cells that are genetically identical, is partly an inevitable...
  • Illustration of amyloid plaques in Alzheimer's disease

    Elixiron’s enrupatinib shows upbeat interim phase II AD results

    BioWorld
    Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...
  • Brain with puzzle piece removed

    Gene replacement rescues autism-related phenotypes in mice

    BioWorld Science
    Autism spectrum disorder (ASD), developmental epileptic encephalopathies and other neurodevelopmental disorders are driven by the disruption of genes regulating...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing